Understanding Gene Therapy for Eye Diseases
Defining Barriers to Gene Therapy
This research explores how gene therapy can help improve vision for people with certain inherited eye conditions that cause vision loss.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11145752 on NIH RePORTER |
What this research studies
Many people experience severe vision loss from inherited eye conditions affecting the light-sensing cells in their eyes. While gene therapy shows promise, earlier attempts improved vision but didn't stop the disease from getting worse. This project aims to discover if gene therapy can still be effective even after the retina is already damaged. We want to find the best time to give gene therapy to improve vision in conditions like rod and cone dystrophies. We are also looking into whether a very small number of healthy cells can still lead to significant vision improvement.
Who could benefit from this research
Good fit: Patients with inherited rod and cone photoreceptor dystrophies, including rod monochromatism, who are 21 years or older, could potentially benefit from future treatments developed from this research.
Not a fit: Patients with vision loss from causes other than inherited retinal degenerative diseases may not directly benefit from this specific gene therapy approach.
Why it matters
Potential benefit: If successful, this work could lead to more effective gene therapies that restore or preserve vision for individuals with advanced retinal degeneration.
How similar studies have performed: Previous human gene therapy trials for retinal degeneration have shown some improvement in visual function, but this research aims to overcome limitations by focusing on timing and effectiveness in already diseased retinas.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Tsang, Stephen H — Columbia University Health Sciences
- Study coordinator: Tsang, Stephen H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.